Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T19:02:33.485Z.
Calculation as of: 2026-10-06T19:02:33.485Z.
Quote observation: 2026-10-06T19:00:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f522eee919378f7ead273ce64f9b652ac6d8ba1380de8c5eb79fdcf7ed4dc2a
PE RATIO
N/A
Market Cap
$31.50M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.44M
PE Ratio
30.59
TTM Avg
37.13
3Y Avg
14.27
5Y Avg
11.10
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $30.88M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.50M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.63M | N/A | 1.92 | 1.92 | 1.92 |
| CervoMed Inc. (CRVO)vs › | $30.18M | N/A | 876.90 | 876.90 | 876.90 |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 30.59 | 37.13 | 14.27 | 11.10 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.18M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $31.86M | N/A | 344.49 | 512.54 | 512.54 |
| Context Therapeutics Inc. (CNTX)vs › | $29.85M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | N/A | 0.40 | 0.40 | 0.40 |
| Quantum Cyber N.V. (QUCY)vs › | $29.71M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$0.60
Forward EPS (Est.)
$-0.51
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
